T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 0 | 0 | 0 | 55 | 91 |
| Gross Profit | N/A | N/A | N/A | 50 | 91 |
| Operating Expenses | 7,787 | 7,149 | 6,907 | 5,720 | 4,633 |
| Operating Income | -7,787 | -7,149 | -6,907 | -5,665 | -4,542 |
| Interest Expense | 304 | 80 | 86 | 100 | 100 |
| Other Income | 0 | -74 | 73 | -615 | 0 |
| Pre-tax Income | -8,091 | -7,303 | -6,920 | -6,380 | -4,642 |
| Net Income Continuous | -8,091 | -7,303 | -6,920 | -6,374 | -4,642 |
| Net Income | $-8,091 | $-7,303 | $-6,920 | $-6,374 | $-4,642 |
| EPS Basic Total Ops | -3,550.00 | -31,750.00 | -31,250.00 | -29,450.00 | -23,450.00 |
| EPS Basic Continuous Ops | -3,268.03 | -25,165.40 | -24,504.25 | -21,246.67 | -16,602.29 |
| EPS Diluted Total Ops | -3,550.00 | -31,750.00 | -31,250.00 | -29,450.00 | -23,450.00 |
| EPS Diluted Continuous Ops | -3,268.03 | -25,165.40 | -24,504.25 | -21,246.67 | -16,602.29 |
| EBITDA(a) | $-7,627 | $-6,994 | $-6,763 | $-5,523 | $-4,388 |